Results

Total Results: 77 records

Showing results for "stage".

41. Statin Use for the Primary Prevention of CVD in Adults: Clinician-Facing CDS Intervention (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation%20Guide_Statin%20Use%20for%20CVD%20Prevention%20in%20Adults_Clinician%20Facing%20CDS%20Intervention.pdf
    January 01, 2020 - ); a family history of hypercholesteremia; currently pregnant or breastfeeding; a diagnosis of end stage … childbearing potential unless these women are using effective contraception and are not nursing.”7 o End stage … included because their 10-Year risk score is less than 7.5 percent • Patient excluded due to end stage

42. Statin Use for the Primary Prevention of CVD in Adults: Clinician-Facing CDS Intervention (April 2021) (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation%20Guide_Statin%20Use%20for%20CVD%20Prevention%20in%20Adults_Clinician%20Facing%20CDS%20Intervention_2.pdf
    April 01, 2021 - • A diagnosis of end stage renal disease (ESRD) or receiving dialysis therapy. … verificationStatus is ‘confirmed’ clinicalStatus is ‘active,’ ‘relapse,’ or ‘recurrence’ (R4 only) End Stage … verificationStatus is ‘confirmed’ clinicalStatus is ‘active’ no abatement[x]attributes are present End Stage

43. Implementation Guide: Statin Use for the Primary Prevention of CVD in Adults: Clinician-Facing CDS Intervention (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation_Guide_CDS_Connect_Statin_CVD_Clinician_Facing_0.pdf
    September 01, 2022 - • A diagnosis of end stage renal disease (ESRD) or receiving dialysis therapy. … verificationStatus is ‘confirmed’ clinicalStatus is ‘active,’ ‘relapse,’ or ‘recurrence’ (R4 only) End Stage … verificationStatus is ‘confirmed’ clinicalStatus is ‘active’ no abatement[x]attributes are present End Stage

44. Implementation Guide: Statin Use for the Primary Prevention of CVD in Adults: Clinician-Facing CDS Intervention (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/18/2023_CDS_Connect_IG_Statin_CVD_Clinician_Facing.pdf
    January 01, 2023 - • A diagnosis of end stage renal disease (ESRD) or receiving dialysis therapy. … verificationStatus is ‘confirmed’ clinicalStatus is ‘active,’ ‘relapse,’ or ‘recurrence’ (R4 only) End Stage … verificationStatus is ‘confirmed’ clinicalStatus is ‘active’ no abatement[x]attributes are present End Stage

45. Warfarin-Antidepressants Mdia Implementation Guide (doc file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1146/Warfarin-Antidepressants%20MDIA%20Implementation%20Guide.docx
    August 29, 2020 - Implementation Guide Warfarin - Antidepressants Prepared by: MDIA contact information Under funding from AHRQ grants R21 HS023826 and R01 HS025984 MDIA publication No. 002 August 29, 2020 Disclaimer The findings and conclusions in this document are those of the author(s), who are responsible for its content, and do no…

46. Implementation Guide: Statin Use for the Primary Prevention of CVD in Adults: Patient-Facing CDS Intervention (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1056/508_2022_CDS_Connect_IG_Statin_CVD_Patient_Facing_final.pdf
    January 01, 2022 - • A diagnosis of end stage renal disease (ESRD) or receiving dialysis therapy. … verificationStatus is ‘confirmed’ clinicalStatus is ‘active,’ ‘relapse,’ or ‘recurrence’ (R4 only) End Stage … verificationStatus is ‘confirmed’ clinicalStatus is ‘active’ no abatement[x] attributes are present End Stage

47. Implementation Guide: Statin Use for the Primary Prevention of CVD in Adults: Patient-Facing CDS Intervention (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1056/2023_CDS_Connect_IG_Statin_CVD_Patient_Facing.pdf
    January 01, 2023 - • A diagnosis of end stage renal disease (ESRD) or receiving dialysis therapy. … verificationStatus is ‘confirmed’ clinicalStatus is ‘active,’ ‘relapse,’ or ‘recurrence’ (R4 only) End Stage … verificationStatus is ‘confirmed’ clinicalStatus is ‘active’ no abatement[x] attributes are present End Stage

48. CDS Connect - Maintenance and Update Final Report (Year 6) (pdf file)
    cds.ahrq.gov/sites/default/files/AHRQ_Final_Report_2022.pdf
    January 01, 2022 - CDS Connect - Maintenance and Update Final Report (Year 6) CDS Connect Maintenance and Update FINAL REPORT (Year 6 of CDS Connect) Agency for Healthcare Research and Quality 5600 Fishers Lane Rockville, MD 20857 www.ahrq.gov Contract No. 75FCMC18D0047 Prepared by: CMS Alliance to Modernize Healthcare …

49. CDS Connect Pilot Final Report (doc file)
    cds.ahrq.gov/sites/default/files/cds/artifact/18/Pilot%20Report_Final_0.docx
    March 01, 2018 - CDS Connect Pilot Final Report Agency for Healthcare Research and Quality (AHRQ) Acknowledgments Agency for Healthcare Research and Quality (AHRQ) CDS Connect Pilot Report Patient-Centered Outcomes Research Clinical Decision Support Prototype Development and Dissemination Prepared for: Agency for Healthcare Research …

50. AHRQ CEDAR Final Outreach Report (pdf file)
    cds.ahrq.gov/cedar/AHRQ_CEDAR_Final_Outreach_Report_October_2022_508.pdf
    January 01, 2022 - the repository stewards enabled the MITRE team to identify people likely to use CEDAR, setting the stage

51. Statin Therapy for the Prevention and Treatment of Cardiovascular Disease Electronic Clinical Quality Measure.pdf (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/21/Implementation%20Guide_Statin%20Therapy%20for%20the%20Prevention%20and%20Treatment%20of%20CVD%20eCQM%20Artifact_Updated%20Nov%202019.pdf
    November 01, 2019 - medications, who are receiving palliative care, who have hepatic disease or insufficiency, who have end-stage … Value sets needed to be established for computable definitions of ASCVD, end-stage renal disease, hepatic

52. CMS's Million Hearts Model Longitudinal ASCVD Risk Assessment Tool for Shared Decision Making (2021) (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/76/CMSs%20Million%20Hearts%20Model%20Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Shared%20Decision%20Making.pdf
    April 01, 2021 - can follow the activities described in the next section to enhance this artifact to the structured stage

53. CMS's Million Hearts Model Longitudinal ASCVD Risk Assessment Tool for Updated 10-Year ASCVD Risk (April 2021) (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/81/CMSs%20Million%20Hearts%20Model%20Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Updated%2010-Year%20ASCVD%20Risk.pdf
    January 01, 2010 - can follow the activities described in the next section to enhance this artifact to the structured stage

54. CDS Connect Final Report Year 2 (pdf file)
    cds.ahrq.gov/sites/default/files/reports/AHRQ_Final_Report_2018.pdf
    January 01, 2018 - CDS Connect Final Report Year 2 CDS Connect CDS Connect Contract Year 2 Final Report Final Report (Year 2) CDS Connect Prepared for: Agency for Healthcare Research and Quality 5600 Fishers Lane Rockville, MD 20857 www.ahrq.gov Contract No. HHSA290201600001U Prepared by: CMS Alliance to Moderniz…

55. Implementation Guide: Statin Therapy for the Prevention and Treatment of Cardiovascular Disease (CVD): An Electronic Clinical Quality Measure (eCQM)-derived CDS (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/21/2024_CDS_Connect_IG_Statin_Therapy_CVD_eCQM.pdf
    January 01, 2024 - disease or hepatic disease or insufficiency, who have statin-associated muscle symptoms, who have end-stage

56. Statin Therapy for the Prevention and Treatment of Cardiovascular Disease Electronic Clinical Quality Measure (April 2021) (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/21/Implementation%20Guide_Statin%20Therapy%20for%20the%20Prevention%20and%20Treatment%20of%20CVD%20eCQM%20Artifact.pdf
    April 01, 2021 - or hospice care, who have active liver disease or hepatic disease or insufficiency, who have end- stage

57. Implementation Guide: Statin Therapy for the Prevention and Treatment of CVD: An eCQM-derived CDS (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/21/Implementation_Guide_Statin_Therapy_CVD_eCQM_0.pdf
    September 01, 2022 - disease or hepatic disease or insufficiency, who have statin-associated muscle symptoms, or who have end-stage

58. Implementation Guide: Statin Therapy for the Prevention and Treatment of CVD: An eCQM-derived CDS (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/21/Implementation_Guide_Statin_Therapy_CVD_eCQM.pdf
    September 01, 2022 - disease or hepatic disease or insufficiency, who have statin-associated muscle symptoms, or who have end-stage

59. Implementation Guide: Statin Therapy for the Prevention and Treatment of CVD: An Electronic eCQM-Derived CDS (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/21/2023_CDS_Connect_IG_Statin_Therapy_CVD_eCQM.pdf
    January 01, 2023 - disease or hepatic disease or insufficiency, who have statin-associated muscle symptoms, or who have end-stage

60. CMS's Million Hearts Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-Year ASCVD Risk (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/71/Implementation_Guide_CMS_Million_Hearts_ASCVD_Risk_Assessment.pdf
    September 01, 2021 - CMS's Million Hearts Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-Year ASCVD Risk 1 Implementation Guide CMS’s Million Hearts® Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-Year ASCVD Risk Agency for Healthcare Research and Quality 5600 Fishers Lane Rockville, MD 20857 …